UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2016 UpToDate®

Uveitis: Etiology, clinical manifestations, and diagnosis

Author
James T Rosenbaum, MD
Section Editor
Jonathan Trobe, MD
Deputy Editor
Paul L Romain, MD

INTRODUCTION

Uveitis, the process of intraocular inflammation, may result from many causes. Referral to an ophthalmology specialist is indicated for the diagnosis and management of most patients with symptoms suggesting uveal tract inflammation.

The definition of uveitis and its subsets; causes of uveitis and differential diagnosis of underlying conditions; clinical manifestations, diagnosis, and differential diagnosis of uveitis; and the role of the non-ophthalmologist in the diagnostic evaluation of patients with uveitis are described here. The treatment of uveitis is presented separately. (See "Uveitis: Treatment".)

DEFINITIONS

Uveitis is characterized by inflammation of the uvea, which is the middle portion of the eye; the anterior portion of the uvea includes the iris and ciliary body, and the posterior portion of the uvea is known as the choroid (figure 1). The term derives from the Latin word for “grape,” since anatomists once thought that the peeling of the outside of the eye left a grape-like structure beneath.

Inflammation of the anterior uveal tract, characterized by the presence of leukocytes in the anterior chamber of the eye, is called anterior uveitis and is synonymous with iritis. When the adjacent ciliary body is also inflamed, the process is known as iridocyclitis [1].

The presence of leukocytes in the vitreous humor and evidence of active chorioretinal inflammation are diagnostic of intermediate uveitis and posterior uveitis, respectively. Terms used to describe forms of uveitis posterior to the lens include vitritis, intermediate uveitis, pars planitis, choroiditis, retinitis, chorioretinitis, and retinochoroiditis [1].

                  

Subscribers log in here

To continue reading this article, you must log in with your personal, hospital, or group practice subscription. For more information or to purchase a personal subscription, click below on the option that best describes you:
Literature review current through: Nov 2016. | This topic last updated: Mon Sep 26 00:00:00 GMT+00:00 2016.
The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment. Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions. The use of this website is governed by the UpToDate Terms of Use ©2016 UpToDate, Inc.
References
Top
  1. Jabs DA, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 2005; 140:509.
  2. Wertheim MS, Mathers WD, Planck SJ, et al. In vivo confocal microscopy of keratic precipitates. Arch Ophthalmol 2004; 122:1773.
  3. Yeh S, Forooghian F, Suhler EB. Implications of the Pacific Ocular Inflammation uveitis epidemiology study. JAMA 2014; 311:1912.
  4. Yuen BG, Tham VM, Browne EN, et al. Association between Smoking and Uveitis: Results from the Pacific Ocular Inflammation Study. Ophthalmology 2015; 122:1257.
  5. Lin P, Loh AR, Margolis TP, Acharya NR. Cigarette smoking as a risk factor for uveitis. Ophthalmology 2010; 117:585.
  6. Weiss MJ, Velazquez N, Hofeldt AJ. Serologic tests in the diagnosis of presumed toxoplasmic retinochoroiditis. Am J Ophthalmol 1990; 109:407.
  7. Bosch-Driessen LE, Berendschot TT, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology 2002; 109:869.
  8. Margo CE, Hamed LM. Ocular syphilis. Surv Ophthalmol 1992; 37:203.
  9. Suhler EB, Lauer AK, Rosenbaum JT. Prevalence of serologic evidence of cat scratch disease in patients with neuroretinitis. Ophthalmology 2000; 107:871.
  10. Kibadi K, Mupapa K, Kuvula K, et al. Late ophthalmologic manifestations in survivors of the 1995 Ebola virus epidemic in Kikwit, Democratic Republic of the Congo. J Infect Dis 1999; 179 Suppl 1:S13.
  11. Varkey JB, Shantha JG, Crozier I, et al. Persistence of Ebola Virus in Ocular Fluid during Convalescence. N Engl J Med 2015; 372:2423.
  12. Mattia JG, Vandy MJ, Chang JC, et al. Early clinical sequelae of Ebola virus disease in Sierra Leone: a cross-sectional study. Lancet Infect Dis 2016; 16:331.
  13. de Paula Freitas B, de Oliveira Dias JR, Prazeres J, et al. Ocular Findings in Infants With Microcephaly Associated With Presumed Zika Virus Congenital Infection in Salvador, Brazil. JAMA Ophthalmol 2016.
  14. Furtado JM, Espósito DL, Klein TM, et al. Uveitis Associated with Zika Virus Infection. N Engl J Med 2016; 375:394.
  15. Rosenbaum JT. Acute anterior uveitis and spondyloarthropathies. Rheum Dis Clin North Am 1992; 18:143.
  16. Haroon M, O'Rourke M, Ramasamy P, et al. A novel evidence-based detection of undiagnosed spondyloarthritis in patients presenting with acute anterior uveitis: the DUET (Dublin Uveitis Evaluation Tool). Ann Rheum Dis 2015; 74:1990.
  17. Muñoz-Fernández S, de Miguel E, Cobo-Ibáñez T, et al. Enthesis inflammation in recurrent acute anterior uveitis without spondylarthritis. Arthritis Rheum 2009; 60:1985.
  18. Rosenbaum JT. Uveitis. An internist's view. Arch Intern Med 1989; 149:1173.
  19. Henderly DE, Genstler AJ, Smith RE, Rao NA. Changing patterns of uveitis. Am J Ophthalmol 1987; 103:131.
  20. Rothova A, Buitenhuis HJ, Meenken C, et al. Uveitis and systemic disease. Br J Ophthalmol 1992; 76:137.
  21. Obenauf CD, Shaw HE, Sydnor CF, Klintworth GK. Sarcoidosis and its ophthalmic manifestations. Am J Ophthalmol 1978; 86:648.
  22. James DG. Ocular sarcoidosis. Ann N Y Acad Sci 1986; 465:551.
  23. Karma A, Huhti E, Poukkula A. Course and outcome of ocular sarcoidosis. Am J Ophthalmol 1988; 106:467.
  24. Lambert JR, Wright V. Eye inflammation in psoriatic arthritis. Ann Rheum Dis 1976; 35:354.
  25. Lyons JL, Rosenbaum JT. Uveitis associated with inflammatory bowel disease compared with uveitis associated with spondyloarthropathy. Arch Ophthalmol 1997; 115:61.
  26. Paiva ES, Macaluso DC, Edwards A, Rosenbaum JT. Characterisation of uveitis in patients with psoriatic arthritis. Ann Rheum Dis 2000; 59:67.
  27. Malinowski SM, Pulido JS, Goeken NE, et al. The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology 1993; 100:1199.
  28. Messenger W, Hildebrandt L, Mackensen F, et al. Characterisation of uveitis in association with multiple sclerosis. Br J Ophthalmol 2015; 99:205.
  29. Rubsamen PE, Gass JD. Vogt-Koyanagi-Harada syndrome. Clinical course, therapy, and long-term visual outcome. Arch Ophthalmol 1991; 109:682.
  30. Sakata VM, da Silva FT, Hirata CE, et al. Diagnosis and classification of Vogt-Koyanagi-Harada disease. Autoimmun Rev 2014; 13:550.
  31. Greco A, Fusconi M, Gallo A, et al. Vogt-Koyanagi-Harada syndrome. Autoimmun Rev 2013; 12:1033.
  32. Zhang XY, Wang XM, Hu TS. Profiling human leukocyte antigens in Vogt-Koyanagi-Harada syndrome. Am J Ophthalmol 1992; 113:567.
  33. Criteria for diagnosis of Behçet's disease. International Study Group for Behçet's Disease. Lancet 1990; 335:1078.
  34. Mamo JG. The rate of visual loss in Behçet's disease. Arch Ophthalmol 1970; 84:451.
  35. Rosenbaum JT, Bennett RM. Chronic anterior and posterior uveitis and primary Sjögren's syndrome. Am J Ophthalmol 1987; 104:346.
  36. Gold DH, Morris DA, Henkind P. Ocular findings in systemic lupus erythematosus. Br J Ophthalmol 1972; 56:800.
  37. Stafford-Brady FJ, Urowitz MB, Gladman DD, Easterbrook M. Lupus retinopathy. Patterns, associations, and prognosis. Arthritis Rheum 1988; 31:1105.
  38. Rosenbaum JT, Roman-Goldstein S, Lindquist GR, Rosenbaum RB. Uveitis and central nervous system vasculitis. J Rheumatol 1998; 25:593.
  39. Shafran SD, Deschênes J, Miller M, et al. Uveitis and pseudojaundice during a regimen of clarithromycin, rifabutin, and ethambutol. MAC Study Group of the Canadian HIV Trials Network. N Engl J Med 1994; 330:438.
  40. Ambati J, Wynne KB, Angerame MC, Robinson MR. Anterior uveitis associated with intravenous cidofovir use in patients with cytomegalovirus retinitis. Br J Ophthalmol 1999; 83:1153.
  41. Bainbridge JW, Raina J, Shah SM, et al. Ocular complications of intravenous cidofovir for cytomegalovirus retinitis in patients with AIDS. Eye (Lond) 1999; 13 ( Pt 3a):353.
  42. Eadie B, Etminan M, Mikelberg FS. Risk for uveitis with oral moxifloxacin: a comparative safety study. JAMA Ophthalmol 2015; 133:81.
  43. Wefers Bettink-Remeijer M, Brouwers K, van Langenhove L, et al. Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin. Eye (Lond) 2009; 23:2260.
  44. Miserocchi E, Cimminiello C, Mazzola M, et al. New-onset uveitis during CTLA-4 blockade therapy with ipilimumab in metastatic melanoma patient. Can J Ophthalmol 2015; 50:e2.
  45. Malinowski SM, Pulido JS, Folk JC. Long-term visual outcome and complications associated with pars planitis. Ophthalmology 1993; 100:818.
  46. Zein G, Berta A, Foster CS. Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 2004; 12:137.
  47. Leopold IH. The incidence of uveitis in multiple sclerosis. Am J Ophthalmol 1966; 62:540.
  48. Priem HA, Oosterhuis JA. Birdshot chorioretinopathy: clinical characteristics and evolution. Br J Ophthalmol 1988; 72:646.
  49. Shao EH, Menezo V, Taylor SR. Birdshot chorioretinopathy. Curr Opin Ophthalmol 2014; 25:488.
  50. LeHoang P, Ozdemir N, Benhamou A, et al. HLA-A29.2 subtype associated with birdshot retinochoroidopathy. Am J Ophthalmol 1992; 113:33.
  51. Chang GC, Young LH. Sympathetic ophthalmia. Semin Ophthalmol 2011; 26:316.
  52. Lubin JR, Albert DM, Weinstein M. Sixty-five years of sympathetic ophthalmia. A clinicopathologic review of 105 cases (1913--1978). Ophthalmology 1980; 87:109.
  53. Rosenbaum JT. Nibbling away at the diagnosis of idiopathic uveitis. JAMA Ophthalmol 2015; 133:146.
  54. Kaiser PK, Lowder CY, Sullivan P, et al. Chest computerized tomography in the evaluation of uveitis in elderly women. Am J Ophthalmol 2002; 133:499.
  55. de Groot-Mijnes JD, de Visser L, Zuurveen S, et al. Identification of new pathogens in the intraocular fluid of patients with uveitis. Am J Ophthalmol 2010; 150:628.
  56. DARRELL RW, WAGENER HP, KURLAND LT. Epidemiology of uveitis. Incidence and prevalence in a small urban community. Arch Ophthalmol 1962; 68:502.
  57. Kanda T, Shibata M, Taguchi M, et al. Prevalence and aetiology of ocular hypertension in acute and chronic uveitis. Br J Ophthalmol 2014; 98:932.
  58. Juanola X, Loza Santamaría E, Cordero-Coma M, SENTINEL Working Group. Description and Prevalence of Spondyloarthritis in Patients with Anterior Uveitis: The SENTINEL Interdisciplinary Collaborative Project. Ophthalmology 2016; 123:1632.
  59. Jabs DA, Busingye J. Approach to the diagnosis of the uveitides. Am J Ophthalmol 2013; 156:228.
  60. Lou SM, Larkin KL, Winthrop K, et al. Lack of consensus in the diagnosis and treatment for ocular tuberculosis among uveitis specialists. Ocul Immunol Inflamm 2015; 23:25.
  61. Rosenbaum JT, Wernick R. The utility of routine screening of patients with uveitis for systemic lupus erythematosus or tuberculosis. A Bayesian analysis. Arch Ophthalmol 1990; 108:1291.
  62. Hong BK, Khanamiri HN, Bababeygy SR, Rao NA. The utility of routine tuberculosis screening in county hospital patients with uveitis. Br J Ophthalmol 2014; 98:1091.
  63. Ang M, Wong W, Ngan CC, Chee SP. Interferon-gamma release assay as a diagnostic test for tuberculosis-associated uveitis. Eye (Lond) 2012; 26:658.
  64. Rosenbaum JT, Rahn DW. Prevalence of Lyme disease among patients with uveitis. Am J Ophthalmol 1991; 112:462.
  65. Prieto JF, Dios E, Gutierrez JM, et al. Pars planitis: epidemiology, treatment, and association with multiple sclerosis. Ocul Immunol Inflamm 2001; 9:93.
  66. Harper TW, Miller D, Schiffman JC, Davis JL. Polymerase chain reaction analysis of aqueous and vitreous specimens in the diagnosis of posterior segment infectious uveitis. Am J Ophthalmol 2009; 147:140.